India Glycols (BOM:500201) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500201 India Glycols Ltd BOM:500201
63 GF Score
Price ₹253.35
GF Value ₹801.71
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is India Glycols Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of India Glycols is: Moderate Risk: Sensitive, better choose undervalued stock.

India Glycols  (BOM:500201) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

India Glycols Risk Assessment Related Terms

BOM:500201 vs DOW: Risk Assessment Comparison

For the Chemicals subindustry, India Glycols's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

India Glycols Risk Assessment vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, India Glycols's Risk Assessment distribution charts can be found below:

* The bar in red indicates where India Glycols's Risk Assessment falls into.


BOM:500201
63GF Score
India Glycols Ltd BOM:500201
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is India Glycols (BOM:500201) Overvalued in 2026?

Based on GuruFocus' analysis, India Glycols stock appears to be undervalued. The current stock price of ₹253.35 is trading 68.4% below its estimated GF Value™ of ₹801.71. GuruFocus considers India Glycols to be Significantly Undervalued.

Key valuation signals for BOM:500201:

  • Risk Assessment:
  • GF Value™: ₹801.71 vs. price of ₹253.35 (68.4% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

India Glycols Business Description

Other Exchanges INDIAGLYCO:India
Address Plot No. 2B, Sector - 126, District Gautam Budh Nagar, Noida, UP, IND, 201304
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
63GF Score

Get the complete analysis for BOM:500201

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹253.35
Price
₹801.71
GF Value